78 related articles for article (PubMed ID: 3972726)
1. Vanoxonin, a new inhibitor of thymidylate synthetase. II. Structure determination and total synthesis.
Kanai F; Isshiki K; Umezawa Y; Morishima H; Naganawa H; Takita T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jan; 38(1):31-8. PubMed ID: 3972726
[TBL] [Abstract][Full Text] [Related]
2. Vanoxonin, a new inhibitor of thymidylate synthetase. III. Inhibition of thymidylate synthetase by vanoxonin-vanadium complex.
Kanai F; Kaneko T; Morishima H; Isshiki K; Takita T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jan; 38(1):39-50. PubMed ID: 3972727
[TBL] [Abstract][Full Text] [Related]
3. Vanoxonin, a new inhibitor of thymidylate synthetase.
Kanai F; Sawa T; Hamada M; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1983 Jun; 36(6):656-60. PubMed ID: 6874588
[TBL] [Abstract][Full Text] [Related]
4. trans-5-(3,3,3-Trifluoro-1-propenyl-)-2'-deoxyuridylate: a mechanism-based inhibitor of thymidylate synthetase.
Wataya Y; Matsuda A; Santi DV; Bergstrom DE; Ruth JL
J Med Chem; 1979 Apr; 22(4):339-40. PubMed ID: 430474
[No Abstract] [Full Text] [Related]
5. Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cells.
Jackson RC; Jackman AL; Calvert AH
Biochem Pharmacol; 1983 Dec; 32(24):3783-90. PubMed ID: 6661252
[TBL] [Abstract][Full Text] [Related]
6. A potent multisubstrate analogue inhibitor of human thymidylate synthetase.
Srinivasan A; Amarnath V; Broom AD; Zou FC; Cheng YC
J Med Chem; 1984 Dec; 27(12):1710-7. PubMed ID: 6502602
[TBL] [Abstract][Full Text] [Related]
7. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
[TBL] [Abstract][Full Text] [Related]
8. Folate-based inhibitors of thymidylate synthase: synthesis and antitumor activity of gamma-linked sterically hindered dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Bavetsias V; Jackman AL; Marriott JH; Kimbell R; Gibson W; Boyle FT; Bisset GM
J Med Chem; 1997 May; 40(10):1495-510. PubMed ID: 9154971
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thymidylate synthetase of the human lymphocytes.
Haurani FI
Cancer Biochem Biophys; 1979; 4(2):75-7. PubMed ID: 317899
[TBL] [Abstract][Full Text] [Related]
10. Human thymidylate synthetase--III. Effects of methotrexate and folate analogs.
Szeto DW; Cheng YC; Rosowsky A; Yu CS; Modest EJ; Piper JR; Temple C; Elliott RD; Rose JD; Montgomery JA
Biochem Pharmacol; 1979 Sep; 28(17):2633-7. PubMed ID: 518674
[No Abstract] [Full Text] [Related]
11. The synthesis and thymidylate synthase inhibitory activity of L-gamma-L-linked dipeptide and L-gamma-amide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Bisset GM; Bavetsias V; Thornton TJ; Pawelczak K; Calvert AH; Hughes LR; Jackman AL
J Med Chem; 1994 Sep; 37(20):3294-302. PubMed ID: 7932557
[TBL] [Abstract][Full Text] [Related]
12. Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717.
Taylor GA; Jackman AL; Calvert AH; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():379-82. PubMed ID: 6720435
[No Abstract] [Full Text] [Related]
13. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors.
Balzarini J; de Clercq E; Ayusawa D; Seno T
FEBS Lett; 1984 Jul; 173(1):227-32. PubMed ID: 6745430
[TBL] [Abstract][Full Text] [Related]
14. 5(E)-(3-azidostyryl)-2'-deoxyuridine 5'-phosphate is a photoactivated inhibitor of thymidylate synthetase.
De Clercq E; Balzarini J; Chang CT; Bigge CF; Kalaritis P; Mertes MP
Biochem Biophys Res Commun; 1980 Dec; 97(3):1068-75. PubMed ID: 7470133
[No Abstract] [Full Text] [Related]
15. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
Jackman AL; Calvert AH; Hart LI; Harrap KR
Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
[No Abstract] [Full Text] [Related]
16. 5-Ethyl-2'-deoxyuridine-5'-monophosphate inhibition of the thymidylate synthetase from Escherichia coli.
Walter RD; Gauri KK
Biochem Pharmacol; 1975 May; 24(9):1025-7. PubMed ID: 1098667
[No Abstract] [Full Text] [Related]
17. Perspective on the design and biochemical pharmacology of inhibitors of thymidylate synthetase.
Santi DV
J Med Chem; 1980 Feb; 23(2):103-11. PubMed ID: 6987403
[No Abstract] [Full Text] [Related]
18. Enhancement by thymidine of 5-fluorouracil's inhibition of thymidylate synthetase in human tumors.
Wolberg WH
Cancer Treat Rep; 1979; 63(11-12):1817-20. PubMed ID: 526916
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of 5-nitro-2'-deoxyuridine by in vivo inhibition of thymidylate synthetase.
Washtien W; Matsuda A; Wataya Y; Santi DV
Biochem Pharmacol; 1978; 27(22):2663-6. PubMed ID: 215163
[No Abstract] [Full Text] [Related]
20. Thymidylate synthase inhibition in cells with arrested DNA synthesis is not due to an allosteric interaction in the replitase complex.
Rode W; Jastreboff MM; Bertino JR
Biochem Biophys Res Commun; 1985 Apr; 128(1):345-51. PubMed ID: 3921023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
